{'fraction_non_alphanumeric': 0.02149767108563239, 'fraction_numerical': 0.0, 'mean_word_length': 6.140664961636829, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Interventional Strategies to Delay Aging Related Diseases & Conditions of the Musculoskeletal System

Aging leads to several geriatric syndromes including frailty, a condition characterized by loss of functional reserve and tissue regeneration repair capacity. Frail individuals exhibit significant mobility and psychological deficits resulting in significant healthcare costs. Thus, identifying strategies to delay aging, or prevent the progressive loss of tissue homeostasis and functional reserve associated with frailty, will dramatically restore function and independence in millions of elderly patients and significantly improve quality of life. We have demonstrated that bone marrow‐derived mesenchymal stem cells (MSCs) and muscle‐derived stem/progenitor cells (MDSPCs) become dysfunctional with age. A fundamental property of aging is the accumulation of senescent cells. Senescence is a cell state defined by loss of proliferative capacity, increased metabolic activity, and importantly, resistance to apoptosis. Senescent cells can release pro‐inflammatory cytokines/chemokines, proteases, and other factors known as the senescence‐associated secretory phenotype (SASP). The SASP can adversely affect not only neighboring cells, but also likely contributes to driving systemic aging. Compounds that selectively target and kill senescent cells were recently identified and characterized. These senolytic drugs target and inhibit anti‐apoptotic pathways that are upregulated in senescent cells thereby inducing apoptotic cell death and abrogating systemic SASP factors. Importantly, senolytic drugs have a favorable safety profile being either FDA approved (dasatinib) or over the counter flavonoid supplements (quercetin, fisetin), positive findings may be more readily translatable to Phase I–II clinical trials. Further, it has been reported that exposure to factors present in the serum of young mice restores the regenerative capacity of aged progenitor cells, through parabiotic pairing. We believe that pregnancy represents a unique biological model of a naturally‐shared circulatory system between young and old organisms. Our preliminary data have demonstrated improved musculoskeletal tissue healing after injury in pregnant mice and improved differentiation capacity of aged muscle progenitor cells (MPCs) after stimulation with serum from pregnant mice. We hypothesize that circulating factors from fetal microchimeric cells (FMCs) during pregnancy have beneficial effects on maternal wound healing, such as reduction in fibrosis for optimal tissue regeneration. In summary, we believe these novel interventional strategies could be used to restore the endogenous stem cell populations in age‐related disorderst to promote healthy aging & to delay age‐related disorders.